Tagorizine

DB20098ExperimentalSmall molecule

Tagorizine is a small molecule drug. The usage of the INN stem '-rizine' in the name indicates that Tagorizine is a antihistaminic/cerebral (or peripheral) vasodilator. Tagorizine has a monoisotopic molecular...

Mechanism: Pharmacologically active on Polyunsaturated fatty acid 5-lipoxygenase and Histamine H1 receptor
Curator reviewed
Formula / weight: C₃₀H₃₆N₄O · 468.645 g/mol (avg)
Also known as: Broizine
Code names: AL-3264

Resolves to

Compound

UNII668QM8QJFSCAS118420-47-6ChEMBLCHEMBL154139

Structure

InChIKeyDVYCNKDRINREMB-WUKNDPDISA-NSMILESCC1=NC=C(\C=C\C(=O)NCCCCN2CCN(CC2)C(C2=CC=CC=C2)C2=CC=CC=C2)C=C1

Targets

P09917ALOX5P35367HRH1

What you can answer from here — as of September 13, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

7+ReferencesStructured and connected to the statements they support

Which drugs share a target with Tagorizine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account